Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Find a Broker »
- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.42 | 0.33 | 26.75 |
| EPS, GAAP | 0.42 | 0.33 | 0.33 |
| Consensus Estimate | 0.38 | 0.31 | 22.58 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.30 | 1.10 | 18.11 |
| EPS, GAAP | 1.30 | 1.10 | 18.11 |
| Consensus Estimate | 1.30 | 1.09 | 19.27 |
| MYGN | Industry Average | |
| P/E (TTM) | 16.39 | NA |
| P/E (Forward) | 15.61 | NA |
| PEG Ratio | 1.02 | 2.20 |
| Price/Sales | 3.67 | 18.91 |
| Beta | 0.64 | 0.70 |
| 2/11/2013 | Bank of America/Merrill Lynch Unveils Secular Growth Stock Buy List (BAC, PETM, HLF, MYGN, ACT, SAH, HEI, FEIC, LOPE) (24/7 Wall St) |
| 11/30/2012 | High Court to Review Patents on Human Genes (WSJ.com) |